Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,467,438
+$218,106 QoQ
Shares Held
5,778
+13.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#2,620
of 4,664 holders
Holding Since
Dec 2025
3 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meramec Financial Planners, LLC holds $4,468,700 across 11 Drug Manufacturers - General names. JNJ ranks #1 (32.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
5,778 | $1,467,438 | |
| 2 | ABBV |
AbbVie Inc.
|
3,729 | $938,365 | |
| 3 | LLY |
ELI LILLY & Co
|
771 | $924,760 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,542 | $583,647 | |
| 5 | NVS |
Novartis AG
|
1,554 | $243,542 | |
| 6 | PFE |
Pfizer Inc
|
8,431 | $203,018 | |
| 7 | AMGN |
Amgen Inc
|
150 | $54,318 | |
| 8 | SNY |
Sanofi
|
1,025 | $43,726 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,467,438 | 5,778 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,249,332 | 5,111 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,060,618 | 5,125 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||